Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis (SEER)

This study has been completed.
Sponsor:
Collaborators:
Seer Pharmaceuticals
CF Therapeutics Development Network Coordinating Center
Cystic Fibrosis Foundation Therapeutics
Information provided by:
Ramsey, Bonnie, MD
ClinicalTrials.gov Identifier:
NCT00219882
First received: September 16, 2005
Last updated: December 18, 2007
Last verified: December 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2006
  Estimated Primary Completion Date: No date given